Islet transplantation has recently emerged as an effective therapy and potential cure for type 1 diabetes mellitus. Recent reports show that the two-layer method (TLM), which employs oxygenated perfluorochemical (PFC) and University of Wisconsin (UW) solution, is superior to simple cold storage in UW for pancreas preservation in islet transplantation. Moreover, we recently reported that islet yield was significantly higher in the ET-Kyoto solution with ulinastatin (MK)/PFC preservation solution compared with the UW/PFC preservation solution in the porcine model and that the advantages of MK solution are trypsin inhibition and less collagenase inhibition. In this study, we compared ulinastatin with another trypsin inhibitor, Pefabloc, in preservation solution for islet isolation. Islet yield before purification was higher in the MK/PFC group compared with the ET-Kyoto with Pefabloc (PK)/PFC group. The stimulation index was higher for the MK/ PFC group than for the PK/PFC group. These data suggest that ET-Kyoto with ulinastatin was the better combination for pancreas preservation than ET-Kyoto with Pefabloc. Based on these data, we now use ET-Kyoto solution with ulinastatin for clinical islet transplantation.
INTRODUCTION
and transplantation with NHBDs using the modified Ricordi method (Kyoto islet isolation method) effectively cures type 1 diabetes (23). The transplantation rate (trans-Since the report of the Edmonton protocol (37) , islet transplantation has advanced significantly and more than plantation number/isolation number) is more than 80%, higher than recently published data using brain-dead 600 type 1 diabetes patients in more than 50 institutions have undergone islet transplantation to cure their dis-heart-beating donors (14, 21, 31) . The isolation method includes an in situ cooling system for pancreas procure-ease. The cadaveric pancreas is injured due to brain death, hypotension, and vasopressor therapy, and subsequently ment (19), ductal injection (28), the modified two-layer method (MK/PFC) (27, 30) , and iodixanol-based purifi-from warm ischemia after donor cross-clamping and cold ischemic storage. There is a clear relationship be-cation (14) . We previously showed that MK/PFC preservation significantly improved islet yields, compared tween these injuries and the reduced success of subsequent islet isolation (4, 12) . In Japan, pancreatic islets with UW/PFC preservation (30) . MK solution includes a trypsin inhibitor (ulinastatin), which is one of the ad-are isolated from non-heart-beating donors (NHBDs) for clinical islet transplantation because donations from vantages of this solution. Indeed, pancreas preservation using MK solution was superior to preservation with heart-beating brain-dead donors are only two to five cases per year and most of their pancreata are used for ET-Kyoto solution without the trypsin inhibitor in a rat model (30) . pancreas organ transplantation. We therefore need to develop an efficient isolation technique for NHBD pan-In this study, we compared ulinastatin with another trypsin inhibitor, Pefabloc, in preservation solution for creata.
We have recently demonstrated that islet isolation islet isolation. 542 NOGUCHI ET AL.
MATERIALS AND METHODS
method described in the Edmonton protocol (15, 16, 33, 34, 37) . In brief, after decontamination of the pancreas, Preservation Solution the ducts were perfused in a controlled fashion with a We used ET-Kyoto solution (5,32) with ulinastatin cold enzyme blend of Liberase HI (1.4 mg/ml; Roche (Miraclid, Mochida Pharmaceutical, Tokyo, Japan;
Molecular Biochemicals, Indianapolis, IN). The dis-ET-Kyoto + ulinastatin = "MK solution") or Pefabloc tended pancreas was then cut into nine pieces, placed in (Roche Applied Science, Germany; ET-Kyoto + Pefa a sterilized Ricordi chamber, and shaken gently. While bloc = "PK solution"). The components of the solutions the pancreas was being digested by recirculating the enare shown in Table 1 . zyme solution through the Ricordi chamber at 37°C, we monitored the extent of digestion with dithizone staining Measurement of Trypsin Inhibition Ability of Solutions by taking small samples from the system. Once diges-In order to assess the trypsin inhibition of MK solution was completed, RPMI-1640 medium (Gibco, Carlstion, PK solution, and ET-Kyoto solution without trypbad, CA) was introduced into the system, and the system sin inhibitors (control), 3 ml of 0.3 mM N-benzoyl-Lwas cooled to stop further digestive activity. The diarginine ethylester reagent (BAEE; Sigma, Tokyo, Japan) gested tissue was collected and washed with fresh mewere incubated for 5 min at 25°C and then 5 µl of 1 dium to remove the enzyme. The phase I period was mg/ml trypsin and 45 µl of each solution were added. defined as the time between placement of the pancreas Trypsin activity was measured by absorption spectroin the Ricordi chamber and the start of collecting the photometry (λ253 nm) using BAEE for the trypsin subdigested pancreas. The phase II period was defined as strate, according to a previous report (17) . Absorbance the time between the start and end of collection. was measured every minute for 6 min. A BAEE unit Islets were purified with a continuous density gradiwas defined as a change in optical density of 0.001/min. ent with Iodixanol-Kyoto solution in an apheresis system (COBE 2991 cell processor, Gambro Laboratories, Porcine Islet Isolation Denver, CO). Because Iodixanol has a lower viscosity Porcine pancreata were obtained at a local slaughterthan Ficoll, it needs less force during centrifugation, house. The operation was started about 10 min after the which causes less damage to islets. For the solution, cessation of heart beating. After removing the pancreas, low-density (density: 1.077) and high-density (density: we immediately inserted a cannula into the main pancre-1.100-1.125) Iodixanol-Kyoto solutions were produced atic duct, infused each preservation solution for ductal by changing the volumetric ratio of Iodixanol and Kyoto protection, and put the pancreas into a two-layer presersolution. vation container that had one of the preservation solutions (preservation solution/PFC). Operation time was Islet Evaluation defined as the time elapsed between the start of opera-
The crude number of islets in each diameter class was tion and removal of the pancreas. Warm ischemic time determined by counting islets after dithizone staining (3 (WIT) was defined as the time elapsed between cessamg/ml, final concentration) (Sigma Chemical Co., St. tion of heart beating and placement of the pancreas into Louis, MO) using an optical graticule. The crude numthe preservation solution. Cold ischemic time (CIT) was ber of islets was then converted to the standard number defined as the time elapsed between placement of the of islet equivalents (IE; diameter standardizing to 150 pancreas into the preservation solution and the start of µm) (35) . Gross morphology was qualitatively assessed islet isolation.
by two independent investigators scoring the islets for Islet isolation was conducted in accordance with the shape (flat vs. spherical), border (irregular vs. wellrounded), integrity (fragmented vs. solid/compact), uniformity of staining (not uniform vs. perfectly uniform), 
MK PK
Each parameter was graded from 0 to 2 with 0 equaling the worst and 2 the best score, so that the worst islet Na (mmol/L) 100 100 K (mmol/L) 43.5 43.5 preparations were given a cumulative score of 0 and the Gluconate (mmol/L) 100 100 best a score of 10. Spherical, well-rounded, solid/com-Phosphate (mmol/L) 25 25 pact, uniformly stained, and large islets were character-Trehalose (mmol/L) 120 120
ized as the best islets.
Hydroxyethyl starch (g/L) 30 30 Islet viability after purification was assessed using Ulinastatin (×10 3 U/L) 100 acridine orange (10 µmol/L) and propidium iodide (15 Pefabloc (mg/L) -1000 µmol/L) (AO/PI) staining to visualize living and dead islet cells simultaneously (3, 16, 35) . Fifty islets were in-times per week. Normoglycemia was defined when two consecutive blood glucose level measurements showed spected and their individual viability was determined visually, followed by calculation of their average viability less than 200 mg/dl. No statistical differences in either pretransplantation blood glucose levels or pretransplan- (16) .
tation body weight were observed among the four groups In Vitro Assessment of Islet Function of mice. Mouse studies were approved by the Institutional Animal Research Committees of Kyoto Univer-Islet function was assessed by monitoring the insulin secretory response of the purified islets during glucose sity, Nagoya University, and Fujita Health University. stimulation according to a procedure described by Sha-Statistical Analysis piro and colleagues (37) . Briefly, 1200 IE were incubated with either 2.8 or 25 mM glucose in RPMI-1640 Values for the data represent the mean ± SE. Two or for 2 h at 37°C and 5% CO 2 . The supernatants were three groups were compared by Student's t-test with collected and insulin levels were determined using a Bonferroni correction. commercially available enzyme-linked immunosorbent RESULTS assay (ELISA) kit (ALPCO Insulin ELISA kit; ALPCO Diagnostics, Windham, NH). The stimulation index was Inhibition of Trypsin Activity calculated by determining the ratio of insulin released Previous reports show that trypsin inhibition with from islets in high glucose concentration to the insulin TLM preservation improves islet yields (17, 30) . We exreleased in a low concentration. The data were normalamined whether MK and PK solutions inhibited trypsin ized to total protein from the cell lysate. All assessments activity. Both solutions inhibited trypsin activity (Fig. 1 ) were made in triplicate and the data (mean ± SE) were compared with ET-Kyoto solution (control) (p < 0.01), expressed as a percentage of the control values in each suggesting that these solutions could be useful in reducexperiment to eliminate variables caused by differences ing trypsin activity during pancreas preservation. among donor pancreata.
Recently, Goto et al. showed that the measurement of the ADP/ATP ratio correlated with transplantation outcome (8) . The ADP/ATP ratio was measured to evaluate the energy status of cultured islets, using the Apo Glow TM kit (Cambrex Bio Science Nottingham Ltd., Nottingham, UK). In brief, 80 IEs were washed in PBS and then mixed with 100 µl of nucleotide-releasing reagent for 10 min at room temperature. Thereafter, 20 µl of nucleotide-monitoring reagent was added to the solution. The ATP levels were measured using a luminometer (FB 12 Luminometer, Berthold Detection Systems GmbH, Pforzheim, Germany) and expressed as the number of relative light units (RLU). After 10 min, the ADP in the solution was converted to ATP by adding 20 µl ADP converting reagent and then measured as the number of RLU. Subsequently, the ADP/ATP ratio of the islets was calculated.
In Vivo Assessment of Islet Function
Mice with severe combined immunodeficiency disease (SCID; CLEA Japan, Inc., Meguro, Tokyo) were used for the experiments. The recipients were rendered nonfasting blood glucose levels were monitored three Porcine Islet Isolation Characteristics significant differences in characteristics between the two groups. The characteristics of porcine islet isolation protocols are shown in Table 2 . There were no significant differ-Assessment of Islet Function In Vitro and In Vivo ences in pancreas size, operation time, WIT, or CIT between the two groups. Phase I and phase II periods were
Recently, Goto et al. showed that the measurement of the ADP/ATP ratio correlated with transplantation also similar for the two groups.
Islet yield before purification was significantly higher outcome (8) . To assess the islet graft function of each group in vitro, the ADP/ATP ratio was measured. There in the MK/PFC group (n = 5) than the PK/PFC group (n = 3) (MK/PFC; 9676 ± 635 IE/g, PK/PFC; 6999 ± was no significant difference in ADP/ATP ratio between the groups (data not shown). 844 IE/g, p < 0.05) ( Fig. 2A) . The islet yield after purification for the MK/PFC group was higher than the PK/ To assess the islet graft function of each group in vivo, 2000 IE of each group were then transplanted be-PFC group (MK/PFC; 6608 ± 927 IE/g, PK/PFC; 4964 ± 1153 IE/g) but not significantly so (Fig. 2B) . Other por-low the kidney capsule of STZ-induced diabetic SCID mice. There was no significant difference between the cine islet characteristics are shown in Table 3 . The stimulation index was higher for the MK/PFC group than groups with respect to the attainability of posttransplantation normoglycemia (data not shown). Morphologic for the PK/PFC group (p < 0.05). There were no other studies showed the presence of islets under the kidney pancreas preservation, and ET-Kyoto/PFC preservation without ulinastatin resulted in lower islet yields (30) . In capsule of all SCID mice 30 days after transplantation. The islet grafts of each group in the normoglycemic this study, we showed that MK solution was synthetically superior to PK solutions. It may be due to differ-mice showed intense insulin staining (data not shown).
Taken together, these data suggest that MK/PFC ences in inhibitory effects of cytokines. Ulinastatin has been shown to inhibit not only trypsin activity but also preservation is superior to PK/PFC preservation.
the release of neutrophil elastase. It also downregulates DISCUSSION transcription of tumor necrosis factor mRNA, the activation of endothelial cells, and the expression of ICAM-1 Islet allotransplantation can achieve insulin independence in patients with type 1 diabetes (37) . Since the induced by endotoxin in vitro (1,2,18 ). It has been shown that administration of ulinastatin decreased the Edmonton protocol was announced, islet transplantations from brain-dead donors (9,10) as well as from non-ischemia-reperfusion injury (38) and attenuated the elevation of inflammatory cytokines and C-reactive protein, heart-beating donors (13, 14, 21) and living donors (15) have been performed. These advances were based on a marker of inflammation (41) in transplanted small intestine. advanced pancreas transport systems (10, 16, 17, 30) , revised immunosuppressant protocols (24, 25) , improved
In conclusion, we show that ET-Kyoto with ulinastatin is a better combination for pancreas preservation islet isolation methods (17) , and enhanced islet engraftment (26). Although experiments of β-cell regeneration than ET-Kyoto with Pefabloc. Based on these data, we now use the ET-Kyoto solution with ulinastatin for clini-from stem cells have proceeded (20, 22, 29) , there is still no reliable method for producing β-cells. Until a new cal islet transplantation from NHBD pancreata. MK/ PFC preservation makes it feasible to use NHBDs for method to generate β-cells is developed, improving the efficacy of islet transplantation seems the most realistic efficient islet transplantation into type 1 diabetes patients. and prudent method to cure diabetes.
Donor pancreata are usually preserved with Univer- including ulinastatin, eliminated trypsin activity during
